---
title: "Jacobio Pharmaceuticals files HKEX next-day disclosure return on share repurchase cancellation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293742613.md"
description: "Jacobio Pharmaceuticals filed a HKEX disclosure regarding share repurchases on July 24, 2026. The company bought 99,000 ordinary shares for treasury at HKD 5.01–5.03 each, totaling HKD 496,950. No shares were repurchased for cancellation. Consequently, issued shares excluding treasury decreased to 782,178,180, while treasury shares increased to 9,576,900."
datetime: "2026-07-24T10:40:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293742613.md)
  - [en](https://longbridge.com/en/news/293742613.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293742613.md)
generator: "portal-rs"
---

# Jacobio Pharmaceuticals files HKEX next-day disclosure return on share repurchase cancellation

-   Jacobio repurchased 99,000 ordinary shares on July 24, 2026 for treasury at HKD 5.01–5.03; aggregate cost HKD 496,950. \* Shares repurchased for cancellation: 0. \* Issued shares excluding treasury fell to 782,178,180; treasury shares rose to 9,576,900. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260724-12256044), on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Jacobio Pharmaceuticals Group: Revenue up 1499% and net profit reached RMB600.6 million, fueled by major licensing deals](https://longbridge.com/en/news/296791061.md)
- [China Medical System Revises Interim Dividend for First Half of 2026](https://longbridge.com/en/news/296184471.md)
- [Marshall Wace discloses net short position in Capital B shares](https://longbridge.com/en/news/296625312.md)
- [Kuaishou files HKEX next-day disclosure return, share capital rises by 213,553 shares](https://longbridge.com/en/news/296482134.md)
- [Sino Biopharm declares 2026 interim dividend of HKD 0.07 a share](https://longbridge.com/en/news/296324109.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**